Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 7/20 | 0.45 |
| ▸ | FNTB | P49356 | 7/20 | 0.45 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30128682 | 1.00 | MME (0.51) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL6791475 | 1.00 | MME (0.51) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL30496770 | 0.96 | MME (0.49) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL29793176 | 0.92 | MME (0.46) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL8002689 | 0.92 | ACE (0.47) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL11324778 | 0.87 | MME (0.52) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL11324786 | 0.87 | MME (0.52) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL8528255 | 0.87 | MME (0.52) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL8528253 | 0.87 | MME (0.52) | MMEPTGS1SLC7A11FNTAFNTB | |
| SCHEMBL29615053 | 0.86 | MME (0.46) | MMEFNTAFNTBSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11597757-B2 | Peptide for treating cancer | SAINT LEO UNIVERSITY (US) | 2023-03-07 | — | — | US | claimed |
| CN-112972395-B | Capsule preparation and preparation method and application thereof | 湖北舒邦药业有限公司 | 2022-12-13 | — | — | CN | claimed |
| EP-4034243-A2 | PEPTIDE FOR TREATING CANCER | Saint Leo University (US) | 2022-08-03 | — | — | EP | claimed |
| CN-101668522-A | Composition and method for binding acetaldehyde in stomach | BIOHIT OYJ | 2010-03-10 | — | — | CN | claimed |
| CN-101489545-A | Food composition for binding acetaldehyde | BIOHIT OYJ (FI) | 2009-07-22 | — | — | CN | claimed |
| US-20250074944-A1 | ACYLATED tRNA, INTRODUCTION OF PHARMACOLOGICALLY ACTIVE MOTIF IN PEPTIDE USING RIBOSOME CATALYSIS AND METHOD OF PREPARING SAME | POSTECH Research and Business Development Foundation (KR) | 2025-03-06 | — | — | US | disclosed |
| CN-119432795-A | Deoxyribotransferase mutant and preparation method, application and use method thereof | 苏州创美生物技术有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-118459540-A | Piezoelectricity small molecule dipeptide and preparation method and application thereof | 南京工业大学 | 2024-08-09 | — | — | CN | disclosed |
| US-20240247029-A1 | INTERLEUKIN-1 RECEPTOR MODULATORS AND USES THEREOF | VALORISATION-RECHERCHE, LIMITED PARTNERSHIP (CA) | 2024-07-25 | — | — | US | disclosed |
| CN-117551198-A | Nanometer antibody for resisting human and mouse B7-H3 and application thereof | 常州市第一人民医院 | 2024-02-13 | — | — | CN | disclosed |
| CN-114369150-B | Mptx2 protein and application thereof in treating methicillin-resistant staphylococcus aureus infection related diseases | 上海市儿科医学研究所 | 2023-10-31 | — | — | CN | disclosed |
| US-20230331863-A1 | COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE AND HTT-LOWERING AGENT FOR TREATMENT OF HUNTINGTON'S DISEASE | VACCINEX INC (US) | 2023-10-19 | — | — | US | disclosed |
| CN-114369150-A | Mptx2 protein and application thereof in treating methicillin-resistant staphylococcus aureus infection-related diseases | 上海市儿科医学研究所 | 2022-04-19 | — | — | CN | disclosed |
| CN-101668522-B | Composition and method for binding acetaldehyde in stomach | BIOHIT OYJ | 2015-06-24 | — | — | CN | disclosed |
| CN-101668522-A | Composition and method for binding acetaldehyde in stomach | BIOHIT OYJ | 2010-03-10 | — | — | CN | disclosed |
| CN-101489545-A | Food composition for binding acetaldehyde | BIOHIT OYJ (FI) | 2009-07-22 | — | — | CN | disclosed |
| US-20040087000-A1 | Isopenicillin N synthetase and deacetoxycephalosporin C synthetase enzymes and method | ISIS INNOVATION LIMITED | 2004-05-06 | — | — | US | disclosed |
| US-20030088058-A1 | ISOPENICILLIN N SYNTHETASE AND DEACETOXYCEPHALOSPORIN C SYNTHETASE ENZYMES AND METHODS | ISIS INNOVATION LIMITED (GB) | 2003-05-08 | — | — | US | disclosed |
| EP-0932685-A2 | ISOPENICILLIN N SYNTHETASE AND DEACETOXYCEPHALOSPORIN C SYNTHETASE ENZYMES AND METHOD | ISIS INNOVATION LIMITED (GB) | 1999-08-04 | — | — | EP | disclosed |
| WO-1998016648-A2 | ISOPENICILLIN N SYNTHETASE AND DEACETOXYCEPHALOSPORIN C SYNTHETASE ENZYMES AND METHODS | ISIS INNOVATION LIMITED (GB) | 1998-04-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240247029-A1 | INTERLEUKIN-1 RECEPTOR MODULATORS AND USES THEREOF | IL1R1, IL1RN, IL1A | MME 2020/4885PTGS1 67/4885SLC7A11 2658/4885 |
| US-20250074944-A1 | ACYLATED tRNA, INTRODUCTION OF PHARMACOLOGICALLY ACTIVE MOTIF IN PEPTIDE USING RIBOSOME CATALYSIS AND METHOD OF PREPARING SAME | NSUN3, RNGTT, TRMT1 | MME 1546/4885PTGS1 3107/4885SLC7A11 2671/4885 |
| US-20030088058-A1 | ISOPENICILLIN N SYNTHETASE AND DEACETOXYCEPHALOSPORIN C SYNTHETASE ENZYMES AND METHODS | DAO, DHPS, COASY | MME 2346/4885PTGS1 2269/4885SLC7A11 2933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.